BioAnalix Inc.

BioAnalix delivers rapid, ultra-sensitive diagnostics for rare and complex conditions

Our self-powered microfluidic platform automates assays, detects diverse biomarkers, and enables multi-panel testing across fluids, environmental, and food samples.
Accessible. Scalable. Precise.

Revolutionizing Gene Therapy with Lab-on-Chip Microfluidics

We are building a compact platform to simulate, program, and deliver gene therapies with precision.
Our chip:

  • Tests genetic payloads (mRNA, siRNA, CRISPR, viral vectors) in parallel
  • Miniaturizes the entire gene editing environment
  • Enables immune-response engineering with macrophages and T cells
  • Uses AI modeling for rapid design and validation
  • Scales from lab prototyping to roll-to-roll manufacturing


Faster. Smarter. More precise gene therapy.

Targeted Innovation for Rare Disease Diagnosis & Treatment

We develop microfluidic platforms for limited-volume samples and scalable roll-to-roll systems with laser precision.
We accelerate breakthroughs in:

  • Rare disease biomarker discovery
  • Point-of-care diagnostics
  • Personalized therapy development


Toronto-based. Globally focused.

In Collaboration With